February 6, 2023

Volume XIII, Number 37

Advertisement

February 06, 2023

Subscribe to Latest Legal News and Analysis

February 03, 2023

Subscribe to Latest Legal News and Analysis

ICYMI: US House Passes Recreational Marijuana Bill

It was April Fools’ Day, but it was not a joke. On April 1, the U.S. House of Representatives voted to legalize marijuana. The bill, dubbed the MORE Act, was passed mostly along party lines by a vote of 220-204. Just three Republicans voted in favor and two Democrats opposed. 

If the MORE Act becomes law, it would deschedule marijuana by removing it from the list of federally banned drugs under the Controlled Substances Act. Marijuana products would be subject to a federal excise tax, starting at 5% for the first two years after enactment and rising to 8% by the fifth year of implementation. An “Opportunity Trust Fund” would be created, where half of the tax revenue would support a “Community Reinvestment Grant Program,” ten percent would support substance abuse programs, and forty percent would go the federal Small Business Administration to support implementation of a newly created equitable licensing grant program. Marijuana producers and importers would need to obtain a federal permit, and they would also need to pay $1,000 per year in federal taxes for each premises they operate. 

The MORE Act, however, is expected to fail in the Senate. Partly because of the politics, but also because the Senate has its own comprehensive bill on marijuana reform called the Cannabis Administrative and Opportunity Act (the “CAO Act”), which is set to be reintroduced later this month following several months of public comment and revisions. As opposed to the MORE Act, the CAO Act would impose a 25% excise tax on marijuana products. The gap, experts suggest, is too wide, creating what seems will be an inevitable deadlock, and another year of failed reforms. 

©2023 Strassburger McKenna Gutnick & GefskyNational Law Review, Volume XII, Number 98
Advertisement
Advertisement
Advertisement

About this Author

Healthcare providers face a host of legal issues such as regulatory compliance considerations, transactional business developments, cash flow problems, employment matters, and litigation. A constant concern is finding cost-effective ways of managing business while not compromising on the highest levels of patient care.

At Strassburger McKenna Gutnick & Gefsky our healthcare attorneys understand these issues and remain at the forefront of this constantly evolving profession.

412-281-5423
Advertisement
Advertisement
Advertisement